PET-CT在肿瘤放射治疗中的应用

夏伟; 罗全勇; 袁志斌

PET-CT在肿瘤放射治疗中的应用

夏伟 , 罗全勇 , 袁志斌

文章导航 > 国际放射医学核医学杂志 > 2006, 30 > 6: (331-335)

引用本文:

Citation:

PET-CT在肿瘤放射治疗中的应用

1. 200060 上海, 上海市普陀区人民医院核医学科;
2. 200233 上海, 上海交通大学附属第六人民医院核医学科
中图分类号: R814.42;R817.4

Application of PET-CT for radiotherapy of the patient with carcinoma

1. Department of Nuclear Medicine, Shanghai Putuo People's Hospital, Shanghai Jiaotong University, Shanghai 200060, China;
2. Department of Nuclear Medicine, Shanghai Sixth People's Hospital, Shanghai Jiaotong University, Shanghai 200233, China
CLC number: R814.42;R817.4

摘要: PET-CT作为一种集解剖影像与生物功能代谢影像为一体的先进影像设备,与放射治疗计划系统相结合,在恶性肿瘤的诊断、分期、影像指导治疗计划以及随访方面起着重要的作用,尤其在肿瘤精确放射治疗过程中的靶区勾画、放射治疗计划的优化等方面具有重要意义。
- 体层摄影术,发射型计算机 /
- 体层摄影术,X线计算机 /
- 肿瘤 /
- 放射疗法
Abstract: PET-CT is an advanced imaging instrument combing anatomical and metabolic information into one. Combined with the radiation planning system, PET-CT is playing an increasingly important tool in the diagnosis and staging of malignant disease, image-gulded therapy planning, and treatment monitoring. Especially, PET-CT has a significant role in the delineation of tumor target volume, optimization of radiation planning.
- Tomography, emission-computed /
- Tomography, X-ray computed /
- Neoplasms /
- Radiotheraply
本作品遵循Signature-Non-Commercial Use 4.0 International (CC BY-NC 4.0)协议

[1]	Ling CC, Humm J, Larson S, et al. Towards multidimensional radiotherapy (MD-CRT):biological imaging and biological conformality. Int J Radiat Oncol Biol Phys, 2000, 47(3):551-560.
[2]	MacManus MP, Hicks BJ, Ball DL, et aL F-18 fluorodeoxyglucose positron emission tomography staging in radical radiotherapy candidates with nonsmall cell lung carcinoma:powerful correlation with survival and high impact on treatment. Cancer, 2001, 92(4):886-895.
[3]	Vanuytsel LJ, Vansteenkiste JF, Stroobants SG, et al. The impact of (18)F-fluoro-2-dexoxy-D-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small cell lung cancer. Racliother Oncol,2000, 55(3):317-324.
[4]	Bradley JD, Perez CA, Dehdashti F, et al. Implementing biologic target volumes in radiation treatment planning for non-small cell lung cancer. J Nucl Med, 2004, 45(suppl 1):S96-S101.
[5]	Erdi YE, Bosenzweig K, Erdi AK, et al. Radiotherapy treatment planning for patients with non-small cell lung cancer using positron emission tomography (PET). Radiother Oncol, 2002, 62(1):51-60.
[6]	Schmidt S, Nestle U, Walter K, et al. Optimization of radioth-erapy planning for non-small cell lung cancer(NSCLC) using ¹⁸FDG-PET.Nuklearmedizin, 2002, 41(5):217-220.
[7]	Schmucking M, Baum RP, Griesinger F, et al. Molecular wholebodycancer staging using positron emission tomography:consequences for therapeutic management and metabolic radiation treatment planning Recent Results Cancer Res, 2003, 162(1):195-202.
[8]	刘俐,孙世良.适形调强放射治疗技术.中国肿瘤,2004,13(3):194-196.
[9]	Akhuret T, Downey RJ, Ginsberg MS, et al. An initial experience with FDG-PET in the imaging of residual disease after induction therapy for lung cancer. Ann Thorac Surg, 2002, 73(1):259-264.
[10]	Magnani P, Carretta A, Bizzo G, et al. FDG/FET and spiral CT image fusion for medistinal lymph node assessment of non-small cell lung cancer patients. J Cardiovasc Surg, 1999, 40(5):741-748.
[11]	Kieman PD, Sheridan MJ, Lamberti J, et al. Mediastinal staging of non-small cell lung carcinoma using computed computed and positron-emission tomography. South Med J, 2002, 95(10):1168-1172.
[12]	Mah K, Caldwell CB, Ung YC, et al. The impact of ¹⁸FDG-PET on target and critical organs in CT-based treatment planning of patients with poorly defined non-small cell lung carcinoma:a prospective study. Int J Radiat Oncol Biol Phys, 2002, 52(2):339-350.
[13]	Caldwell CB, Mall K, Ung YC, et al. Observer variation in contouriag gross tumor volume in patients with poorly defined nonsmall-cell lung tumors on CT:the impact of ¹⁸FDG-hybrid PET fusion. Int J Badiat Oncol Biol Phys, 2001, 51(4):923-931.
[14]	余党凡,左传涛,戴嘉中,等.FDG-PET/CT在鼻咽癌放疗后随访中的初步应用研究.癌症,2004,23(增1):1538-1541.
[15]	胡永成.全国骨转移瘤治疗专题座谈会会议纪要.中华骨科杂志,2003,23(6):323-325.
[16]	Even-Sapir E, Metser U, Flusser G, et al. Assessment of malignant skeletal disease:initial experience with (18)F-fluoride PET/CT and comparison between (18)F-Fluoride PET and (18)F-fluoride PET/CT. J Nucl Meal, 2004, 45(2):272-278.
[17]	朱晓霞,陈永清,陈龙华.PET/CT图像融合对骨转移瘤放射治疗肿瘤区勾画的影响.第一军医大学学报,2004,24(6):700-702.
[18]	张立颖.¹⁸F-FDG PET显像在恶性淋巴瘤中的应用.国外医学·放射医学核医学分册,2001,25(1):10-12.
[19]	Nehmeh SA, Erdi YE, Ling CC, et al. Effect of respiratory gating on reducing lung motion artifacts in PET imaging of lung cancer.Med Phys, 2002, 29(3):366-371.

[1]	陈香 , 赵晋华 . PET及PET-CT在监测肿瘤治疗效果中的价值. 国际放射医学核医学杂志, 2007, 31(6): 354-358.
[2]	叶慧 , 莫逸 , 谢爱民 , 彭翔 . ¹⁸F-氟脱氧葡萄糖PET-CT与99nTc-亚甲基二膦酸盐骨显像诊断转移性骨肿瘤的对比研究. 国际放射医学核医学杂志, 2008, 32(3): 147-150.
[3]	宋少莉 , 黄钢 . ¹⁸F-氟脱氧葡萄糖PET监测实体瘤放化疗疗效的应用进展. 国际放射医学核医学杂志, 2007, 31(5): 284-288.
[4]	陈跃 . 颅内肿瘤放射治疗后¹⁸F-氟代脱氧葡萄糖PET的临床意义. 国际放射医学核医学杂志, 2006, 30(2): 97-99.
[5]	吕慧清 , 张中民 , 吕仲虹 . ¹⁸F-氟代脱氧葡萄糖PET在恶性肿瘤适形放射治疗中的价值. 国际放射医学核医学杂志, 2006, 30(6): 335-337.
[6]	宋建华 , 赵晋华 , 邢岩 . 胸、腹部肿瘤PET-CT扫描方案的设置与选择. 国际放射医学核医学杂志, 2007, 31(6): 349-353.
[7]	汪太松 , 赵晋华 , 宋建华 . PET或PET-CT在肿瘤筛查中的应用价值. 国际放射医学核医学杂志, 2007, 31(6): 337-341.
[8]	隗功华 , 孙晓光 . 医学影像学在肿瘤治疗疗效评价中的应用. 国际放射医学核医学杂志, 2009, 33(1): 43-46. doi: 10.3760/cma.j.issn.1673-4114.2009.01.043
[9]	张玉娜 , 赵晋华 . ¹⁸F-氟脱氧葡萄糖PET-CT在头颈部肿瘤临床诊治中的价值. 国际放射医学核医学杂志, 2007, 31(6): 359-362.
[10]	朱苏雨 , 胡炳强 . PET-CT用于肿瘤精确放疗靶区勾画的困惑. 国际放射医学核医学杂志, 2007, 31(4): 217-221.